Trial site
Uniwersytecki Szpital Kliniczny Im. Fryderyka Chopina W Rzeszowie
- 40running trials
- 27closed trials
The trials here
What the 67 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)18 trials
- Psoriasis14 trials
- Hidradenitis suppurativa12 trials
- Chronic spontaneous urticaria6 trials
- Alopecia areata4 trials
- Lung cancer4 trials
- Vitiligo3 trials
- Nephrotic syndrome2 trials
- Hearing loss1 trial
- Lichen planus1 trial
- Lupus (SLE)1 trial
- Mesothelioma1 trial
- and 1 more
- Phase
- Phase 339 trials
- Phase 222 trials
- Phase 13 trials
- Phase 2/33 trials
- Status
- Completed26 trials
- Active, not recruiting22 trials
- Recruiting14 trials
- Not yet recruiting4 trials
- Withdrawn1 trial
- Lead sponsor
- Incyte Corporation6 trials
- Takeda5 trials
- Galderma R&D3 trials
- Nektar Therapeutics3 trials
- Novartis Pharmaceuticals3 trials
- and 37 more
Running trials
Not yet recruiting
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Active, not recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Active, not recruiting
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Active, not recruiting
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Recruiting
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)5 recruiting
- Psoriasis3 recruiting
- Chronic spontaneous urticaria2 recruiting
- Nephrotic syndrome2 recruiting
- Alopecia areata1 recruiting
- Hidradenitis suppurativa1 recruiting
- Lichen planus1 recruiting
- Lung cancer1 recruiting
- Lupus (SLE)1 recruiting
- Multiple myeloma1 recruiting
- Vitiligo1 recruiting
Closed trials
Recruiting
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Completed
Terminated
Completed
Efficacy and Safety of ANB032 in the Treatment of Subjects with Atopic Dermatitis
Completed
Recruiting
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Completed
Single-dose Study of BMS-986326 at Two Dose Levels in Participants with Atopic Dermatitis
Completed
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Site data: ClinicalTrials.govUpdated 19 Nov 2026